Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update November 2022

Links to the MHRA Drug Safety Update for November 2022 are listed below.

• Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management

• Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you

• COVID-19 vaccines and medicines: updates for November 2022

• Letters and medicine recalls sent to healthcare professionals in October 2022

You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts

Published: 02/12/2022. Medicines Update blogs are correct at the time of publishing